Medical Condition

oncology

Total Trials

13

Recruiting Now

13

Trial Phases

Phase 4, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for oncology sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — oncology Clinical Trials

How many clinical trials are currently recruiting for oncology?

ClinicalMetric currently tracks 13 actively recruiting clinical trials for oncology, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 13. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for oncology?

oncology research spans Phase 1 (3 trials), Phase 2 (2 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a oncology clinical trial?

Eligibility criteria for oncology trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 4

Top Sponsors

Radboud University Medical Center 1 trial

Isala 1 trial

xCures 1 trial

Société des Produits Nestlé (SPN) 1 trial

OncoCareClinic 308 Ltd 1 trial

Recruiting Clinical Trials

NCT07680556

Recruiting

Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma

Radboud University Medical Cen...

View Trial →

NCT06031233 Phase 4

Recruiting

Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie

xPedite: A Study to Expedite DIPG and DMG Research

Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends

Société des Produits Nestlé (S...

View Trial →

NCT06222801

Recruiting

The 1st Tumor CytokinoTherapy Database (TCTD-1)

OncoCareClinic 308 Ltd

View Trial →

NCT04075305

Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Enrollment

8,000 pts

Location

United States, Austr...

Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors

Impact of Acupuncture and Manual Therapies on Patients' Quality-of-life in a Hospital-to-community Continuum

Carmel Medical Center

View Trial →

NCT06326411 Phase 1

Recruiting

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

Enrollment

230 pts

Location

United States, Austr...

Sponsor

Nested Therapeutics, Inc

View Trial →

NCT05776680

Recruiting

The Effects of Multi-Psycho-Oncology Care Courses

National Taiwan University Hos...

View Trial →

NCT05197972

Recruiting

Assessment of Cardiac Coherence Associated With Medical Hypnosis on Preoperative Anxiety in Oncological Surgery

Institut du Cancer de Montpell...

View Trial →

NCT05344209 Phase 2

Recruiting

Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer

Vestre Viken Hospital Trust

View Trial →

NCT05320588 Phase 1, Phase 2

Recruiting

A Study in Patients With Advanced Cancers

BiOneCure Therapeutics Inc.

View Trial →

Related Conditions

solid tumor adult (2) cancer (2) infusion reaction (1) dipg (1) dmg (1) cerebral palsy cp (1) breast cancer (1) prostate cancer (1) gynecologic cancer (1) brain tumor (1) brain cancer (1) gynecologic tumor (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology